Intratumoral CD8(+) T cells as a potential positive predictor of chemoimmunotherapy response in PD-L1-negative advanced gastric cancer patients: a retrospective cohort study

BACKGROUND: Previous studies have shown that PD-L1-positive advanced gastric cancer (GC) patients could achieve clinical benefit after receiving immune checkpoint inhibitors (ICI) in initial or subsequent therapy. A number of prospective studies such as Keynote-158 have demonstrated that PD-L1-negat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Gangling, Zhu, Meiqin, Chen, Yaoxu, Wang, Shubo, Cheng, Boran, Wang, Shubin, Liao, Wangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459198/
https://www.ncbi.nlm.nih.gov/pubmed/36092315
http://dx.doi.org/10.21037/jgo-22-644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459198/
https://www.ncbi.nlm.nih.gov/pubmed/36092315
http://dx.doi.org/10.21037/jgo-22-644

Ejemplares similares